Cite Filings / COLL / 0001104659-25-012907
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G

Statement of Beneficial Ownership

COLLEGIUM PHARMACEUTICAL, INC · Filed 2025-02-13 · Acc 0001104659-25-012907

Documents 1

  • SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

  • 2025-05-02 SCHEDULE 13G Statement of Beneficial Ownership
  • 2025-02-13 SCHEDULE 13G Statement of Beneficial Ownership
  • 2025-02-12 4 Director acquired 4,820 shares (grant or award)
  • 2025-02-12 4 EVP and Chief Medical Officer gave up 5,897 shares (to pay taxes)
  • 2025-02-12 4 EVP & Chief Commercial Officer gave up 29,623 shares (to pay taxes)
  • 2025-02-12 4 EVP & Chief Financial Officer gave up 30,426 shares (to pay taxes)
  • 2025-02-07 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · FULLER & THALER ASSET MANAGEMENT, INC. 1.84%
  2. 2026-11-16 SCHEDULE 13G/A · JANUS HENDERSON GROUP Ltd. 0.2%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…